MSRPS
ANIP icon

Maryland State Retirement & Pension System’s ANI Pharmaceuticals ANIP Stock Holding History

Maryland State Retirement & Pension System’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Buy
2,662
+49
+2% +$3.93K ﹤0.01% 1346
2026
Q1 		$201K Hold
2,613
– – ﹤0.01% 1299
2025
Q4 		$206K Buy
2,613
+134
+5% +$11.6K ﹤0.01% 1303
2025
Q3 		$227K Sell
2,479
-2,521
-50% -$206K ﹤0.01% 1260
2025
Q2 		$326K Buy
5,000
+143
+3% +$9.31K 0.01% 1211
2025
Q1 		$325K Sell
4,857
-745
-13% -$44.5K 0.01% 1188
2024
Q4 		$310K Hold
5,602
– – 0.01% 1350
2024
Q3 		$334K Buy
5,602
+256
+5% +$15.6K 0.01% 1315
2024
Q2 		$340K Sell
5,346
-133
-2% -$8.63K 0.01% 1345
2024
Q1 		$358K Hold
5,479
– – 0.01% 1297
2023
Q4 		$302K Sell
5,479
-422
-7% -$23.2K 0.01% 1393
2023
Q3 		$343K Buy
5,901
+476
+9% +$27.5K 0.01% 1278
2023
Q2 		$292K Buy
+5,425
New +$240K 0.01% 1396

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Maryland State Retirement & Pension System's ANIP Position: Q2 2026 in Review

Maryland State Retirement & Pension System increased its ANI Pharmaceuticals (ANIP) stake by 1.9% in Q2 2026, buying an estimated $3.93K and bringing the position to 2,662 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #1346.

Maryland State Retirement & Pension System first reported a position in ANIP in Q2 2023 and has held it in 13 quarters since. The position peaked at $358K in Q1 2024. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Maryland State Retirement & Pension System held 2,662 shares of ANI Pharmaceuticals worth $220K as of Q2 2026.
  • Maryland State Retirement & Pension System bought 49 ANI Pharmaceuticals shares in Q2 2026, an estimated $3.93K.
  • ANI Pharmaceuticals made up ﹤0.01% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #1346 holding.
  • Maryland State Retirement & Pension System first reported a position in ANI Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • Maryland State Retirement & Pension System's ANI Pharmaceuticals position peaked at $358K in Q1 2024.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.